Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ: KNSA · Real-Time Price · USD
46.35
+0.19 (0.41%)
Mar 9, 2026, 3:23 PM EDT - Market open
KNSA Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 677.56 | 423.24 | 270.26 | 220.18 | 38.54 | Upgrade
|
| Revenue Growth (YoY) | 60.09% | 56.61% | 22.75% | 471.24% | - | Upgrade
|
| Cost of Revenue | 307.22 | 189.22 | 89.93 | 46.97 | 9.94 | Upgrade
|
| Gross Profit | 370.35 | 234.02 | 180.33 | 173.21 | 28.61 | Upgrade
|
| Selling, General & Admin | 196.27 | 168.01 | 129.43 | 97.95 | 85.95 | Upgrade
|
| Research & Development | 96.85 | 111.62 | 76.1 | 65.49 | 99.3 | Upgrade
|
| Operating Expenses | 293.13 | 279.63 | 205.52 | 163.44 | 185.25 | Upgrade
|
| Operating Income | 77.22 | -45.62 | -25.2 | 9.77 | -156.64 | Upgrade
|
| Other Non Operating Income (Expenses) | 11.65 | 9.46 | 8.54 | 1.25 | 0.1 | Upgrade
|
| Pretax Income | 88.87 | -36.15 | -16.65 | 11.03 | -156.54 | Upgrade
|
| Income Tax Expense | 29.86 | 7.04 | -30.74 | -172.34 | 1.39 | Upgrade
|
| Net Income | 59.01 | -43.19 | 14.08 | 183.36 | -157.92 | Upgrade
|
| Net Income to Common | 59.01 | -43.19 | 14.08 | 183.36 | -157.92 | Upgrade
|
| Net Income Growth | - | - | -92.32% | - | - | Upgrade
|
| Shares Outstanding (Basic) | 74 | 71 | 70 | 69 | 69 | Upgrade
|
| Shares Outstanding (Diluted) | 79 | 71 | 72 | 70 | 69 | Upgrade
|
| Shares Change (YoY) | 10.58% | -0.69% | 2.13% | 2.69% | 10.89% | Upgrade
|
| EPS (Basic) | 0.80 | -0.60 | 0.20 | 2.64 | -2.30 | Upgrade
|
| EPS (Diluted) | 0.75 | -0.60 | 0.20 | 2.60 | -2.30 | Upgrade
|
| EPS Growth | - | - | -92.31% | - | - | Upgrade
|
| Free Cash Flow | 136.42 | 25.41 | 13.17 | 5.7 | -126.71 | Upgrade
|
| Free Cash Flow Per Share | 1.73 | 0.36 | 0.18 | 0.08 | -1.85 | Upgrade
|
| Gross Margin | 54.66% | 55.29% | 66.72% | 78.67% | 74.22% | Upgrade
|
| Operating Margin | 11.40% | -10.78% | -9.32% | 4.44% | -406.38% | Upgrade
|
| Profit Margin | 8.71% | -10.21% | 5.21% | 83.28% | -409.72% | Upgrade
|
| Free Cash Flow Margin | 20.13% | 6.00% | 4.87% | 2.59% | -328.75% | Upgrade
|
| EBITDA | 78.78 | -43.92 | -22.86 | 12.18 | -154.28 | Upgrade
|
| EBITDA Margin | 11.63% | -10.38% | -8.46% | 5.53% | - | Upgrade
|
| D&A For EBITDA | 1.55 | 1.7 | 2.34 | 2.4 | 2.36 | Upgrade
|
| EBIT | 77.22 | -45.62 | -25.2 | 9.77 | -156.64 | Upgrade
|
| EBIT Margin | 11.40% | -10.78% | -9.32% | 4.44% | - | Upgrade
|
| Effective Tax Rate | 33.60% | - | - | - | - | Upgrade
|
| Revenue as Reported | 677.56 | 423.24 | 270.26 | 220.18 | 38.54 | Upgrade
|
| Advertising Expenses | 12.06 | 11.43 | 9.07 | 5.73 | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.